Brief: BOD Australia Sings Exclusive Licensing And Five-Year Supply Agreement Secured With OTC Medicines Company
02/12/2022 24:52
Dec 2 (Reuters) - BOD Australia Ltd BOD.AX :
* EXCLUSIVE LICENSING AND FIVE-YEAR SUPPLY AGREEMENT SECURED
WITH
OTC MEDICINES COMPANY
* AGREEMENT TO COMMERCIALISE A UNIQUE SCHEDULE 3 CBD
PRODUCT
Source text for Eikon: urn:newsml:reuters.com:*:nASX9TlYrK
Further company coverage: BOD.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bod Science
See all newsBrief: Bod Science Says Adrian Sturrock To Step Down As CFO
Brief: Bod Science Executes Agreement To Acquire Issued Share Capital In Biortica Agrimed
Brief: Bod Science Announces Further Delay In Lodgement Of Appendix 4D & Half Year Report
Brief: Bod Science Says Now Entered Doca With Biortica In Accordance With Doca Proposal
Brief: Bod Science Announces Medicinal Cannabis Supply Agreement With Green Farmers Pty